Perspective
Our work in Perspective
-
Vaccines Help Reduce COVID-19 Related Anxiety and Depression
COVID-19 vaccines may offer individuals more than protection from serious illness caused by the virus— they may also reduce COVID-related anxiety and depression.
Categorized in -
The Burden of 1 Million Excess Deaths: 13.5 Million Years of Life Lost During the COVID Pandemic
Analysis of excess deaths two years into the pandemic finds adults younger than 65 years old made up 56% of life years lost.
Categorized in -
Aduhelm Decision Shows Medicare is Making a Mistake in the Fight Against Alzheimer’s
The medical need is too great that the FDA should not limit targeted therapies and diagnostics.
Categorized in -
Improving Care of People With Serious Medical Illness—An Economic Research Agenda for Palliative Care
More people are living with serious illness as the population ages, and patients with socioeconomic disadvantages bear the greatest burdens of poor care.
Categorized in -
Improving Care of People with Serious Medical Illness: An Economic Research Agenda for Palliative Care
In 2020, Schaeffer Center established an Advisory Panel on Palliative Care. In this post, the panel outlines next steps to increase the quality of care of frail people with multiple chronic conditions.
Categorized in -
California Should Lead on Health Technology Assessment
California has the opportunity to take the lead on incorporating value-based pricing of health technology in the state healthcare system.
Categorized in -
We Should Double Down on Treatments for Those at High Risk Instead of Pushing Boosters and Tests for Everyone
Billions of dollars now committed to home-testing masses of people could be saved if we tested only the symptomatic. Those funds would be better spent supporting access to affordable COVID treatment for people with a high risk of hospitalization.
Categorized in -
Who Are the Winners in the No Surprises Act?
With the No Surprises Act set to take effect January 1, HHS is resisting a push from some doctor groups to weaken implementation rules of the legislation, and that’s a good thing. The law is a big win for patients, employers, and consumers.
Categorized in -
Middlemen, Not Drug Companies, Are Pushing Up Insulin Prices, and Congress Doesn’t Have the Right Plan to Fight Back
Congress should take advantage of the current political climate and start reining in the intermediaries in the drug distribution system.
Categorized in